Hepitope Pty Ltd
Overview
Hepitope is developing a novel DNA vaccine technology that promotes both humoral and cell mediated immune responses. The system improves the efficacy of nucleic acid vaccines by targeting of antigens to both Major Histocompatability Complex (MHC) I and MHC II pathways.
Current focus is on the development of vaccines for chronic infections such as HIV and Hepatitis.
Specific focus of company
Seeking partnerships and collaborations with other pharmaceutical and biotechnology companies.
Core Business Definition
Vaccine Technologies.
Main business focus/
Listing by sector:
- Vaccines & Adjuvants
Corporate Alliances/Partnerships
Interested in forming partnerships and collaborations with other pharmaceutical and biotechnology companies.
Contact Details
| Address | 205 Grattan St |
|---|---|
| City/Suburb | Carlton |
| State | Victoria |
| hazel@burnet.edu.au | |
| Phone | +61 3 8344 3189 |
| Fax | +61 3 9347 5888 |
